NCT05805605
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Biphenotypic Acute Leukemia, +54 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
Clinical trial condition
Relapsed Chronic Lymphocytic Leukemia
Explore clinical trials studying Relapsed Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.
8 public trials
2 recruiting studies
Relapsed Chronic Lymphocytic Leukemia trial results
NCT05246345
- Conditions
- CLL, Chronic Disease, Chronic Lymphocytic Leukemia, +18 more
- Locations
-
- CHU d'Amiens Amiens, France
- CHU de Besançon Besançon, France
- Hopital AVICENNE Bobigny, France
- CHU clermont-ferrand Clermont-Ferrand, France
NCT01750567
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
Completed
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
NCT04191187
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +56 more
- Locations
-
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
NCT02722668
- Conditions
- Acute Leukemia, Acute Lymphoblastic Leukemia/Lymphoma, Acute Myeloid Leukemia, +74 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
NCT02181478
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +35 more
- Locations
-
- Case Comprehensive Cancer Center Cleveland, Ohio, United States
Active, Not Recruiting
Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT05479994
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
- Locations
-
- Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital Hefei, Anhui, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Beijing Jishuitan Hospital Beijing, Beijing Municipality, China
- Beijing Hospital Beijing, Beijing Municipality, China
Active, Not Recruiting
Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL
NCT04624633
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States